Opinion
Video
Author(s):
Neal Shore, MD, FACS, and Brian Shuch, MD, provide closing thoughts on the potential of PET/CT imaging to improve patient care in kidney cancer.
Pazopanib plus bevacizumab shows promising phase 2 efficacy in ccRCC
Benmelstobart plus anlotinib improves PFS, ORR vs sunitinib in aRCC
Serum glycoproteins may predict response to nivolumab/cabozantinib in aRCC
Ipilimumab / nivolumab significantly improves 12-month nccRCC survival in SUNNIFORECAST
Study reveals disparities in immunotherapy use for patients with kidney, bladder cancer
Systemic therapy after adjuvant IO shows benefit in subset of renal cell carcinoma tumors